Navin Fluorine Reports Robust Q1 FY27 Growth and Outlines Capex Roadmap
Navin Fluorine International Ltd · Intimation · 07 Sept 2026, 6:20 pm
Navin Fluorine Reports Robust Q1 FY27 Growth and Outlines Capex Roadmap Navin Fluorine scheduled physical analyst meetings at the Jefferies India Forum on 16th–17th Sep'26. In Q1 FY27, consolidated net sales grew 44% YoY (+11% QoQ) to Rs. 1,045.1 Cr, while Operating EBITDA rose 73% YoY to Rs. 357.1 Cr with margins at 34.2%. Operating PAT surged 108% YoY to Rs. 243.3 Cr. Segment YoY revenue grew across CDMO (+82%), Specialty Chemicals (+48%), and HPP (+33%). Key growth capex includes a Rs. 236.5 Cr HFC expansion, Rs. 125 Cr Phase II cGMP4 capacity, and Rs. 90 Cr for Advanced Materials.
Original exchange filing (PDF)
More announcements from Navin Fluorine International Ltd
- Intimation of Schedule of Analyst / Institutional Investor Meets · 13 Nov 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 13 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of Navin Fluorine International Limited .... · 11 Nov 2026
- Transcript of Earnings Call held for the quarter and half year ended September 30, 2026 · 06 Nov 2026
- Newspaper Advertisement of the financial results for the quarter and half year ended September 30, 2026 · 31 Oct 2026
- Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's .... · 31 Oct 2026
- Communication to shareholders-Intimation regarding Tax Deduction on Dividend · 30 Oct 2026
- Investor Presentation for Q2 & H1 of Financial Year 2026-27 · 30 Oct 2026
